Skip to main content
. 2021 Mar 24;12:660575. doi: 10.3389/fpsyt.2021.660575

Table 1.

Demographic information, psychopathology, trait measures, substance use severity (means and standard deviations), and percentages of novel psychoactive and comorbid polysubstance use in the past 90 days by group.

Control group n = 35 Recreational group n = 27 Treatment-seeking group n = 20 Statistic, p-value, effect size
Demographics
Age (years) 26.43 (6.84) 25.11 (3.90) 28.95 (5.11) F(2,79) = 2.73, p = 0.07, η2 = 0.07
IQ (NART) 116.17 (6.20) 117.00 (6.79) 114.10 (7.55) F(2,79) = 1.10, p = 0.34, η2 = 0.03
Education (years) 15.20 (2.18) 14.78 (2.03) 14.15 (1.81) F(2,79) = 1.68, p = 0.19, η2 = 0.04
In work or education (%) 100% 96% 40% X2 = 38.80, p < 0.001, V = 0.69
Psychopathology
Trait Anxiety (STAI-T) 38.86 (10.78) 39.32 (10.69) 54.00 (11.11) F(2, 77) = 14.29, p < 0.001, η2 = 0.27
Depression (BDI-II) 6.69 (7.67) 9.20 (8.65) 22.37 (13.35) F(2, 76) = 17.27, p < 0.001, η2 = 0.31
ADHD symptoms (ARSC) 1.97 (1.60) 1.92 (1.61) 4.05 (1.39) F(2, 76) = 13.20, p < 0.001, η2 = 0.26
Childhood adversity (CTQ) 43.91 (10.83) 48.76 (15.58) 63.74 (6.67) F(2, 76) = 17.59, p < 0.001, η2 = 0.32
Impulsiveness/sensation seeking
Impulsivity (BIS-11) 60.11 (11.15) 64.52 (9.39) 73.15 (8.04) F(2, 77) = 11.01, p < 0.001, η2 = 0.22
Sensation seeking (SSS-V total) 19.56 (6.95) 26.72 (4.67) 25.58 (5.03) F(2, 75) = 12.65, p < 0.001, η2 = 0.25
Thrill/adventure seeking 6.24 (2.19) 6.88 (2.71) 6.63 (2.52) F(2,75) = 0.41, p = 0.67, η2 = 0.01
Disinhibition 4.26 (2.57) 7.04 (1.67) 6.95 (2.04) F(2, 75) = 14.94, p < 0.001, η2 = 0.29
Experience seeking 6.03 (1.75) 8.24 (1.69) 7.79 (1.58) F(2, 75) = 14.00, p < 0.001, η2 = 0.27
Boredom susceptibility 3.03 (1.75) 4.56 (1.66) 4.21 (1.81) F(2, 75) = 12.65, p < 0.001, η2 = 0.14
Substance use severity
Age of first NPS use (years) 20.33 (3.22) 21.00 (5.86) t(45) = 0.50, p = 0.62, η2 = 0.01
Alcohol use (AUDIT) 3.91 (2.44) 5.70 (3.45) 11.40 (9.41) F(2, 79) = 13.13, p < 0.001, η2 = 0.25
Cannabis use (CUDIT-R) 0.00 (0.00) 4.19 (3.54) 8.20 (7.34) F(2, 79) = 25.82, p < 0.001, η2 = 0.40
Nicotine use (FTND) 0.37 (1.01) 0.37 (1.26) 1.60 (2.19) F(2, 79) = 5.27, p = 0.01, η2 = 0.19
Drug-sharing behavior (%) 19% 53% X2 = 5.91, p = 0.02, V = 0.36
Drug-injecting behavior (%) 11% 37% X2 = 4.34, p = 0.04, V = 0.31
Novel psychoactive substance use (% past 90 days)
Ketamine 5.7% 60%
Nitrous oxide 44.4% 10%
Mephedrone 7.4% 30%
2C (2CB, 2CE) 29.6% 10%
1-propionyl-lysergic acid diethylamide 25.9% 0%
Synthetic cannabinoids 3.7% 20%
Gamma Hydroxybutyrate 0% 15%
Methoxetamine 0% 15%
Alkyl nitrites (poppers) 14.8% 0%
Ethylphenidate 0% 10%
Salvia divinorum 0% 10%
25I-NBOMe 0% 10%
Kratom (Mitragyna specios) 7.4% 0%
Methylone 0% 5%
Kratom 0% 5%
Other psychedelics not specified 0% 5%
Methoxydine 3.7% 0%
Dimethyltryptamine 3.7% 0%
Kava 3.7% 0%
Kanna 3.7% 0%
Comorbid polysubstance use (% past 90 days)
Alcohol 100% 85%
Cocaine 18.5% 80%
Cannabis 66.6% 55%
Diazepam 7.4% 65%
Ecstasy 33.3% 35%
Amphetamine 14.8% 40%
Methamphetamine 0% 10%
Crack cocaine 0% 10%
Heroin 0% 10%
Lysergic acid diethylamide 3.7% 5%

NART, National Adult Reading Test; AUDIT, Alcohol Use Disorders Identification Test; CUDIT-R, Cannabis Use Disorder Identification Test-Revised; FTND, Fagerström Test of Nicotine Dependence; BDI-II, Beck Depression Inventory; STAI, Spielberger Trait Anxiety Inventory; ARSC, Adult ADHD Self-Report Scale; CTQ, Childhood Trauma Questionnaire, BIS-11, Barratt Impulsiveness Scale; SSS-V, Sensation Seeking Scale. Bold indicates p < 0.05.